Markers of bone turnover for the management of patients with bone metastases from prostate cancer

Garnero, P., Buchs, N., Zekri, J. et al. (3 more authors) (2000) Markers of bone turnover for the management of patients with bone metastases from prostate cancer. British Journal of Cancer, 82 (4). pp. 858-864. ISSN 0007-0920

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2000 Cancer Research Campaign. From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.
Keywords: bone markers; prostate cancer; bone metastases; type I collagen; bisphosphonate; hormone replacement therapy; c-terminal telopeptide; pyridinium cross-links; i collagen; degradation products; alkaline-phosphatase; pagets-disease; urinary pyridinoline; biochemical markers; diagnostic-value
Dates:
  • Published: 20 January 2000
  • Accepted: 6 October 1999
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 08 Aug 2016 11:29
Last Modified: 08 Aug 2016 11:32
Published Version: http://dx.doi.org/10.1054/bjoc.1999.1012
Status: Published
Publisher: Cancer Research UK
Refereed: Yes
Identification Number: https://doi.org/10.1054/bjoc.1999.1012

Share / Export

Statistics